Waters Corp (WAT) is a publicly traded Healthcare sector company. As of May 21, 2026, WAT trades at $341.36 with a market cap of $32.62B and a P/E ratio of 31.62. WAT moved +2.35% today. Year to date, WAT is -13.58%; over the trailing twelve months it is -5.74%. Its 52-week range spans $275.05 to $423.56. Analyst consensus is buy with an average price target of $375.59. Rallies surfaces WAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Waters Corporation Q1 EPS $2.70 and $1.27B Revenue Spur UBS to Raise Target to $375: Waters Corporation posted Q1 earnings of $2.70 per share on revenues of $1.27 billion, its fourth consecutive quarter of beats that lifted its profit forecast. UBS maintained a neutral rating but raised its price target to $375, citing $520 million in revenue from acquired biosciences assets and 11% organic growth.
| Metric | Value |
|---|---|
| Price | $341.36 |
| Market Cap | $32.62B |
| P/E Ratio | 31.62 |
| EPS | $10.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $423.56 |
| 52-Week Low | $275.05 |
| Volume | 3 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.17B |
| Net Income | $642.63M |
| Gross Margin | 59.28% |
15 analysts cover WAT: 0 strong buy, 7 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $375.59.